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             Schizophrenia plagues approximately 1% of the world’s population. This chronic 
brain disorder is marked by behavioral, cognitive and social abnormalities. Studies on the 
brain pathophysiology of schizophrenia have also found predominant structural and 
neurochemical aberrations. While no single cause of the disorder has been identified; 
environmental, genetic and epigenetic factors have been implicated. This thesis is both an 
investigation of the genetically modified GCPII
+/-
 mouse model as well as the 
groundwork for the implementation of diffusion tensor imaging and an updated 
epigenetic mouse model. Groundwork for the updated mouse model included rodent 
stereotactic surgery design to ultimately induce epigenetic dysregulation with hopes of 
better modeling the variable development and symptomology of schizophrenia. The 
primary GCPII
+/- 
mouse model sustains decreased expression of the enzyme glutamate 
carboxypeptidase II (GCPII) integral for glutamate synthesis in order to diminish 
glutamatergic N-methyl-d-aspartate (NMDA) receptor activity. Magnetic resonance 
imaging, spectroscopy and a social task were used to test for the abnormalities that 
GCPII
+/-
 might exhibit. Tests were conducted on both mice heterozygous for GCPII
+/-
mutation (HET) and their wild-type (WT) counterparts at numerous ages corresponding 
to mouse adolescence and adulthood. We hypothesized that HET mice would exhibit 
differential volume of brain structures and neurometabolites compared to WT mice, as 
well as social deficiency.  
  
             Magnetic resonance imaging (MRI) and spectroscopy (MRS) data were obtained 
on post natal days (PND) 35/36, 49/50 and 63/64 and social task data were obtained 
between PND 114 and 117. Both MRI and MRS data revealed sex differences. HET 
males exhibited more structural abnormalities than HET females with greater 
hippocampal asymmetry and decreased right hippocampal volume compared to WT 
males. Ventricular enlargement or asymmetry was not reported in HET males nor 
females. HET females exhibited more abnormalities in neurometabolite levels with 
elevated levels of choline and glutamate, as well as diminished levels of N-
acetylaspartate and N-acetylaspartylglutamate compared to WT females. Behavioral data 
found that both HET males and females exhibit a social deficit. Each sets of results 
mirrored findings in MRI and MRS studies on schizophrenia as well as characteristic 
social abnormalities. Data serve as a testament to the promise of the GCPII
+/-
 mouse 
model but are also indicative of the model’s shortcomings. 
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Introduction to Schizophrenia 
 In 1972, Plum declared schizophrenia to be the “graveyard of neuropathologists” 
(Andreasen 2005). Such a characterization is fitting for a brain disorder with both a 
multitude of symptoms and a variety of potential causes. Approximately 1.1 % of the 
global population suffers from schizophrenia (SZ) and diagnosis is standardized by the 
American Psychological Association (APA) Diagnostic and Statistical Manual of Mental 
Disorders (DSM-IV) and by the International Classification of Diseases criteria (ICD-10) 
(Organization 2004; Association 2000). Both tools detail SZ as a heterogeneous disorder 
that manifests as several subtypes consisting of various sets of symptoms. Symptoms 
include delusions, hallucinations, disorganized speech, disorganized or catatonic 
behavior, flattened affect, speech deficit and avolition, as well as compromised 
independence, interpersonal relations and occupational status (Association 2000). 
Symptoms can be classified either as active-phase or negative. Active-phase symptoms 
can be considered positive symptoms as they are the presentation of abnormalities which 
include hallucinations (visual, auditory, olfactory, and somatosensory) and delusions as 
well as disorganized speech and catatonic behavior (Kay 2007). Negative symptoms are 
the absence of normal behaviors such as deficits in communication, avolition, and 
flattened affect. Those with SZ will also typically exhibit diminished working memory, 
difficulties in attention, compromised independence and occupational dysfunction (Kay 





Onset of symptoms typically occurs during adolescence. Active phase or positive 
symptoms must be present for a month with or without negative symptoms prior to 
diagnosis and must not result from drug use or medical conditions. 
Structural Abnormalities in SZ 
These symptoms comprised much of the known psychopathology of SZ prior to the 
revolution of neuroimaging. Post mortem studies did not find conclusive data due to the 
inconsistencies present in the acquisition of tissues, clinical diagnoses and the more 
qualitative nature of the original exploration into structural abnormalities (Powchik et al. 
1998). While postmortem studies have improved with more specific and advanced 
labeling methods as well as systematic tissue retrieval over the past two decades, they are 
still unable to assess functional abnormalities as well as alterations over time (Shenton et 
al. 2001). Computed Tomography (CT), Magnetic Resonance Imaging (MRI), and 
Diffusion Tensor Imaging (DTI) have emerged as non-invasive tools capable of 
discovering structural abnormalities previously too minute to elucidate. In 1976 Johnston 
et al.’s CT study definitively confirmed findings of enlarged lateral ventricles in SZ 
patients from pneumonencephalography and postmortem brain studies (Johnston et al. 
1976).  
Over the past three decades, MRI data have provided a vast amount of information on the 
structural abnormalities in the schizophrenic brain. Table 1 lists predominant findings 
from a recent review of neuroimaging studies and the associated pathology of specific 
structural abnormalities (Shenton  2010; Shenton 2010). Relevant brain structures and 






Table.1.Predominant structural abnormalities. Their prevalence and associated role in pathophysiology of 











73% Abnormal development and 
neurodegeneration of thalamus 
Reduced Amygdala 74% Implicates pre and perinatal environmental 
assaults 
Diminished emotional expression 




74% Implicates pre and perinatal environmental 
assaults 
Diminished plasticity 
Impairments in cognition and memory 
Reduced Superior 
temporal gyrus 
67% Auditory hallucinations 
Verbal memory deficits 
Thought disorder 
Reduced Frontal Lobe 59% Poor performance in Wisconsin Card Sorting 
Task 
Eye tracking abnormalities 
Spatial working memory deficits 
Reduced Parietal Lobe 60% Thought disorder 
Diminished attention 
Diminished spatial working memory 
Disturbed language ability 
Cavum Septum 
Pellucidum 
92% Disrupted or asymmetric cerebral 
development 
Enlarged Basal ganglia 68% Attributed to drug treatment 




63% Deficit in information processing 
Diminished interhemispheric communication 
Thalamus 42% Diminished attention and information 
processing 
Deficits in modulation of limbic system and 
cortical areas 
Regulates connections between cortex and 
cerebellum 
Cognitive dysmetria 
Cerebellum 31% Cognitive processing 










Fig. 1. Brain structures relevant to schizophrenia pathology. Top image identifies superior temporal gyrus, as 
well as frontal and temporal lobes. Middle image illustrates internal structures on left; thalamus, basal ganglia, 




, and lateral. Bottom image on left presents 
marker enlarged lateral ventricles and cavum septum pellucidum in schizophrenic brain compared to healthy brain on 





Such findings demonstrate the spectrum of brain phenomena observed in SZ. MRI data 
concentrated on volumetric differences in the gray matter of the brain and it was not until 
the application of Diffusion Tensor Imaging that interest grew in assessing white matter. 
The development of DTI in the late 1990s coincided with postmortem brain studies in the 
early 2000’s, the latter of which observed abnormalities in glial cell development in SZ 
(Kubicki et al. 2005). A class of glial cells, oligodendrocytes, comprises the fatty myelin 
sheaths that cover axons. These myelin sheaths are crucial to normal signal propagation 
and sustaining connections among neurons. Demyelination is indicative of neuronal 
breakdown and death (Kubicki et al. 2005). In the brain, axons join together to form 
tracts and bundles. 
Diffusion tensor imaging probes the structural integrity of white matter connections and 
tracts. DTI studies investigate aberrations in organization and viability of axons and the 
connections that they form. The majority of DTI studies have found abnormalities in a 
myriad of fiber tracts responsible for connections between and among the frontal and 
temporal lobes, that play roles in memory, learning, emotion, language, hallucinations as 
well as behavior. 
CT, MRI and DTI greatly enabled researchers to explore structural abnormalities in the 
SZ brains but these means could not elucidate abnormalities in neural activity or 
neurochemistry. The advent of functional magnetic resonance imaging (fMRI) and 
magnetic resonance spectroscopy (MRS) offered the necessary tools for probing the SZ 
brain for such aberrations. Such tools mostly functioned to evaluate the hypotheses 






Psychomimetic Drugs and SZ 
The effects of drugs such as lysergic acid diethylamide (LSD), cocaine, ketamine, and 
phencyclidine (PCP) led to the pharmacologically informed hypotheses of abnormalities 
present in the SZ brain. LSD and cocaine mainly elicit positive symptoms of the disorder 
through their hallucinogenic effects in healthy users and exacerbation in those who 
already suffer from it (Crow 1980). Recently, the LSD mouse model was revisited as a 
means to explore SZ (Marone-Lewicka et al. 2011). This investigation was fueled by the 
dual effect of LSD that consists of both a hallucinogenic phase and a subsequent paranoid 
one.  This study found that these effects of LSD are mediated by both serotonin receptor 
subtype 5HT2 activity and dopamine receptors D2 and D4. D2 receptors and 5HT2 
receptors were found to have been upregulated and downregulated, respectively. Such 
findings are indicative of the agonistic effects of LSD on serotonergic and dopaminergic 
receptors and link hyperactive serotonergic and mesolimbic dopaminergic 
neurotransmission with symptoms of SZ.  
On the other hand the dissociative anesthetics PCP and Ketamine elicit the positive, 
negative and cognitive symptoms characteristic of SZ (Morris et al. 2005). Both of these 
compounds antagonize N-methyl-d-aspartate receptors (NMDAR), one of the main 
ionotropic glutamate receptors in the central nervous system (CNS). 
NMDA Receptors 
NMDARs are ligand gated ion channels that can be found on both pre and post synaptic 
neurons and must be coactivated by both glutamate, the major excitatory neurotransmitter 
of the (CNS), and glycine or d-serine which are present at low levels in the synapse 





simultaneous with sufficient membrane depolarization or else the receptor cannot allow 
ions through. NMDA receptors consequently function as coincidence detectors of 
glutamate release and membrane depolarization, the basis for their role in Hebbian 
synaptic plasticity.   They are crucial for a number of other processes that occur 
throughout the development and maturation of the CNS as well, including synaptic 
transmission, learning and memory and structural modifications of dendrites and 
dendritic spines (Blanke and Vandongen 2009). 
 
 





) and calcium ions (Ca
2+)
 flow through ion channel. (AnaesthesiaUK). 
The effects of PCP and Ketamine implicated NMDAR hypofunction in the 
symptomology of SZ and various phenomena of the disorder. Such phenomena include 
reduced spine densities and compromised dendritic structure in cortical glutamatergic 
neurons (Glantz and Lewis 2000) as well as disrupted parvalbumin positive (PV) 
GABAergic interneurons in cortico-limbic and hippocampal neural circuits (Nakazawa et 





and memory (Lee et al. 2012). NMDA receptors are found on spines and allow for 
independent action potentials within the dendrites (Blanke and Vandogen 2009) leading 
to strengthened structures and increased spine density. It is hypothesized that the 
hypoactivity of these receptors, as in SZ, will result in reduced spine density and 
deteriorated integrity of these structures. 
NMDA receptors are the primary form of excitatory input for GABAergic interneurons, 
thereby establishing the relevance of these interneurons. PV GABAergic interneurons of 
the hippocampus are a subset of GABAergic interneurons which have been shown to be 
significantly more sensitive to NMDAR antagonism than pyramidal neurons (Grunze et 
al. 1996). Disrupted gamma oscillations and cognitive and behavioral defects in SZ are 
taken as evidence for asynchronous neuronal circuits. Nakazawa and his colleagues argue 
that NMDAR hypofunction impairs the fast-spiking neurons responsible for neural 
synchrony. Fast-spiking neurons are mostly comprised of PV GABAergic interneurons, 
which modulate and synchronize neural activity within cortical and hippocampal neural 
circuits by balancing excitation with inhibition.  They play major roles in the proper 
maturation and development of these circuits. These interneurons are responsible for the 
inhibition of subcortical dopaminergic neurons as well as neurons within the 
hippocampus which have been shown to be hyperactive in SZ (Nakazawa et al. 2012, 
Grunze et al. 1996) 
The role of GABAergic interneurons in SZ is further bolstered by evidence that NMDAR 
antagonists, such as ketamine and PCP, decrease levels of the GABA synthesizing 
enzyme, glutamic acid decarboxylase 67 (gad67) and parvalbumin (PV) in cortical 





pyramidal neurons (Coyle 2012). These findings inextricably link hypofunction of 
NMDA receptors with a predominant pathology of SZ. The reduction of gad67 and PV 
demonstrate the differential assault that NMDAR antagonism can have on GABAergic 
function. When considering the role that these interneurons play in healthy brains, 
dysregulation of mesolimbic dopaminergic neurons can be linked to what is observed in 
SZ (Coyle 2012). fMRI studies have also found disrupted connectivity between frontal 
and temporal regions, relevant when considering these mesocortical and mesolimbic 
systems (Lawrie et al. 2002). 
NMDAR antagonism is hypothesized to result from the neurochemical abnormalities 
observed in the SZ. Postmortem studies found reduced levels of glutamate and 
diminished breakdown of the endogenous antagonist, N-acetylaspartyl glutamate 
(NAAG) in the prefrontal cortex and hippocampus of SZ brains (Tsai et al. 1995) while 
MRS studies found diminished levels of glutamate and glutamine (glx) in the frontal 
regions of the brain as well as decreased levels of N-acetyl aspartate (NAA) (Marsman et 
al. 2011).  
Prior to the shift of focus onto NMDAR’s role in SZ pathology, aberrations in 
dopaminergic signaling was the leading hypothesis of SZ pathology due to effects of 
cocaine and LSD previously mentioned. The hypothesis held hyperactive mesolimbic 
dopaminergic neurons responsible for the positive symptoms and hypoactive 
mesocortical dopaminergic neurons responsible for the negative symptoms (Stahl 2007). 
The effects of current day antipsychotics – both typical and atypical – work best to 
alleviate positive symptoms due to their affinity for dopamine receptor subtypes (Coyle 





dopamine is only half the story. PCP and Ketamine did much to shift the focus onto 
NMDAR dysfunction within the context of GABAergic and glutamatergic abnormalities. 
The findings fueled the initial use of the glutamate carboxypeptidase II (GCPII
+/-
) 
knockout mice as a model of NMDAR antagonism.  
GCPII
+/-
 Mouse Model 
GCPII
+/- 
mice are heterozygous mutant mice with one of the two copies of the folate 
hydrolase 1 gene knocked out. It has been hypothesized that this mutation results in 
diminished levels of the enzyme GCPII (Schaevitz et al. 2011) which is found on 
astrocytes, supporting cells of neurons, and is responsible for cleaving N-




Fig. 3. Enzymatic activity of glutamate carboxypeptidase II cleaving N-acetylaspartylglutamate to N-
acetylaspartate and Glutamate. 
It was postulated that diminished levels of GCPII would mirror the pathophysiology of 
SZ by reducing catabolism of NAAG and subsequently reducing levels of glutamate. 
Lower levels of the agonist glutamate and higher levels of the antagonist NAAG were 









Mouse Model: Epigenetics 
In 1991, Gottesman published findings that demonstrated how the risk of developing SZ 
increased as a function of the genetic similarity between unaffected and affected (with 
SZ) relatives. He found that second-degree relatives would have a lesser risk when 
compared to first-degree relatives, and dizygotic twins would have a lesser risk when 
compared to monozygotic twins, who exhibited the highest concordance rate of about 
50% (Lewis and Levitt 2002). Such findings demonstrated the need to consider the role 
that both an individual’s environment and their genetics play in the predisposition to and 
development of SZ. A concordance rate below 100% implicates the interactions that take 
place between genes and the environment (Os et al. 2008).  Epigenetics, the heritable or 
adaptive changes in gene expression comprise these interactions. Such changes in gene 
expression occur via DNA methylation, and/or modifications in the structure and function 
of chromatin or histone proteins (Akbarian 2010). Exploration into epigenetic 
mechanisms was fueled (Akbarian 2010) by the lack of a single genetic abnormality as 
the cause for the development of SZ (Kaminsky et al. 2009). 
Predominant findings among schizophrenics are the diminished expression of the 
glycoprotein Reelin and glutamic acid decarboxylase-67 (GAD67) (Guidotti et al. 2000). 
GAD67 is an important GABA synthesis enzyme that utilizes glutamate as a precursor 
(Guidotti et al 2000). It was posited that such findings were the result of dysregulated 
epigenetic mechanisms. DNA Hypermethylation of promoter regions as well as increased 
conversion to repressive chromatin (Huang and Akbarian 2007) have been correlated 
with these deficiencies. However, this study found that diminished gene expression 





hypermethylation (Huang and Akbarian 2007).  Numerous investigators have proposed 
that specific modifications to residues on histones are the means of defining active and 
repressive chromatin (Jenuwein and Allis 2001, Berger 2002, Iizuka and Smith 2003, 
Peterson and Leniel 2004, Wang et al. 2004). 
Schavetiz et al. explored the role of epigenetic regulation by focusing on one carbon 
metabolism (C1) (Schaevitz et al. 2011). The C1 cycle has been considered the umbrella 
mechanism under assault in SZ because it plays a role in a number of characteristic 
abnormalities of the disorder such as aberrant DNA methylation, NMDAR dysfunction 
and abnormal prenatal levels of folate and homocysteine (Krebs et al. 2009). C1 
metabolism consists of three components; the folate cycle, methionine cycle and 
transsulfuration pathway each of which involve synthesis of nucleotides for maintenance 
of DNA, transfer of methyl groups deriving from dietary folate and homeostasis of  
cellular reduction-oxidation reactions respectively (Schaevitz et al. 2011). The 
methionine cycle mediates DNA methylation and ultimately gene expression and is 
therefore implicated in epigenetic dysregulation (Krebs et al. 2009). Previously 
mentioned abnormalities in GAD67 expression have been connected to aberrant 
hypermethylation of histone proteins which are contingent on the activity of the 
methionine cycle. Studies of postmortem SZ brain tissues have found both significant 
hypo and hyper methylation at different genes related to mitochondrial function, and 
GABAergic and glutamatergic neurotransmission. Diminished levels of folate and 
hyperhomocysteinemia are predominant findings in SZ (Krebs et al. 2009). Lower dietary 
intake of folate is proposed to lead to diminished methylation of homocysteine into 





Schaevitz et al. modeled altered C1 metabolism in GCPII+/-mice by subjecting them to a 
folate deficient diet but found that the mutation and dietary modulation essentially 
cancelled each other out (Schaevitz et al. 2011). Homocysteine and glycine levels can 
increase as a result of a folate deficit (Krebs et al. 2009) and the two can subsequently 
function as NMDAR agonists diminishing the effects of reduced GCPII levels. Wild type 
mice, however, did exhibit social, motor and cognitive abnormalities when fed a folate 
deficient diet (Schaevitz et al. 2011). The “reciprocal interaction” between this folate 
deficient diet and the GCPII knockout suggested the consideration of different ways to 
induce epigenetic dysregulation in GCPII
+/- 
mice as a way to better model the disorder. 
Collaboration with the Akbarian lab has led to plans to introduce the complementary 
DNA (cDNA) of the histone deacetylase enzyme, HDAC1, via the introduction of an 
adenovirus vector for overexpression in the mouse cortex. HDAC1 has been shown to be 
significantly elevated in patients with SZ, and these elevated levels were correlated with 
decreased expression of GAD67 (Sharma et al. 2008). Altering the methylation status in 
the DNA of GCPII
+/- 
mice was not considered because both hypo- and hyper- methylation 
have been exhibited in schizophrenics as a function of gene locus and therefore would not 
be an accurate model of the epigenomic alterations that take place in this disorder 
(Akbarian 2010). When histone proteins are acetylated, the DNA can be transcribed and 
the chromatin is open. When the acetyl groups are removed, i.e. the histone is 
deacetylated, the chromatin is repressed and condensed, transcription is silenced and 
heterochromatin may form leading to a deficit in gene expression (Akbarian 2010).  
 It is anticipated that introduction of HDAC1 cDNA will elevate levels 





a behavioral paradigm will continue to be used to assess volumetric aberrations in brain 
structure and social abnormalities. DTI will be implemented in order to explore the effect 
of genetic and epigenetic assaults on white matter tracts,supplementing the application of 
MRS which measured levels of choline (cho), creatine (Cr), taurine (Tau), N-
acetylaspartate + N-acetylaspartylglutamate (NAA + NAAG) and glutamate + glutamine 
(Glx). 
Role of Metabolites 
The metabolites in this thesis were analyzed because of their relevance to neuronal 
function, neurotransmission, neurodegenerative disorders and the pathology of SZ. 
Choline: Levels of the metabolite choline (Cho) can be indicative of the breakdown of 
myelin or alteration in neuronal membrane compositions (Bracken et al. 2011). In SZ, 
diminished Cho levels have been observed in the left hippocampus (Maier et al. 1995). 
Choline levels have been shown to be positively correlated with memory and attention 
(Bluztajn, 1998). The NMR-visible choline peak is representative of a number of choline-
containing compounds such as glycerophosphocholine, phosphatidylcholine and 
phosphocholine (Govindaraju et al. 2000). Cho serves as precursor to the mononucleotide 
cytidine diphosphate choline, necessary for phospholipid synthesis, explaining its 
relevance to membrane structure.  
Creatine: The metabolite creatine (Cr) is utilized as an internal standard in a number of 
MRS studies (Ongur et al. 2009). All reported levels of metabolites in this thesis are ratio 
values relative to the level of Cr. This metabolite serves to maintain ATP/ADP levels in 
muscles (Andres 2008) and altogether plays a role in brain metabolism and energy. 





findings in this project have affirmed its use (Mu 2011).  
Taurine: Like choline, taurine (Tau) has been shown to be relevant in the maintenance of 
neuronal cell membranes. It is an amino acid that serves to protect membranes and 
promote both neuronal growth and survival (Schuller-Levis and Park 2003). SZ patients 
have exhibited increased levels of Tau in the prefrontal cortex, hypothesized to be in 
response to metabolic deficiencies (Shirayama et al. 2009). Prior data obtained on 
GCPII+/- mice mirrored these findings with significantly higher levels of Tau found in 
the hippocampal region of GCPII+/- mice (Mu 2011).  
N-acetylaspartate and N-acetylaspartylglutamate: The metabolites N-acetylaspartate 
(NAA) and N-acetylaspartyl-glutamate (NAAG) are significant metabolites in SZ 
research. NAA is a highly relevant metabolite in the nervous system and can indicate the 
amount of healthy neurons especially since it has been shown to be reduced in brains that 
have suffered strokes or tumors (Steen et al. 2005). The viability of neurons can be 
ascertained by the number of spines or synapses, and their size or density (Bracken et al. 
2011). A meta-analysis of MRS studies on SZ found that there is a significant reduction 
of NAA levels observed in the hippocampus as well as cortical gray and white matter in 
SZ brains (Steen et al. 2005). Significant correlations have also been found with social 
abnormalities in SZ and NAA metabolite levels (Sigmundsson et al. 2003). NAAG on the 
other hand is a predominant peptide transmitter released during neuronal depolarization 
of glutamatergic and GABAergic neurons (Bergeron and Coyle 2012). It is hypothesized 
to act as an agonist at a subtype of metabotropic glutamate receptors (mGluR3) blocking 
glutamate release, and an antagonist of NMDA receptors blocking neuronal excitation. 





et al 1999). GCPII, the cleaving enzyme found on astrocytes, has also been shown to 
regulate the synaptic concentration of NAAG (Tiffany et al. 2001), thus grounding the 
hypothesis that a reduction of GCPII can result in excess NAAG and therefore NMDAR 
antagonism.  
Glutamate and Glutamine: The final metabolites of interest are glutamate (Glu) and 
glutamine (Gln). Glutamate is the major excitatory neurotransmitter in the CNS. 
Following its release into synaptic clefts, it is taken up by astrocytes and converted to 
glutamine which is then transported to the axon terminals of presynaptic neurons for 
glutamate synthesis (Marsman et al. 2011). Interest in glutamatergic neurotransmission 
stemmed from the antagonistic effects of phencyclidine (PCP) and Ketamine on the 
glutamatergic NMDA receptor (Paz et al. 2008).   An increased glutamine/glutamate ratio 
was reported in rat prefrontal cortex treated with PCP further connecting NMDAR 
dysfunction with glutamatergic neurotransmission (Iltis et al. 2009).   
A review of MRS studies on medial prefrontal cortex and anterior cingulate cortex 
metabolites in schizophrenic brains found that glutamate levels were reduced and that 
levels of glutamine were increased (Marsman et al. 2011). Thus a hypoglutamatergic 
hypothesis of schizophrenia prevailed, which suggested that reduced levels of glutamate 
and consequent diminished excitation of NMDA receptors cause the major phenotypes of 
SZ. Yet numerous findings have since shifted the focus onto hyperglutamatergic activity 
as responsible for the major phenotypes of the disorder (Paz et al. 2008).   
Increased levels of glutamate in rodent prefrontal cortex were reported in rats treated with 
Ketamine (Moghaddam et al. 1997) and were also shown to correlate with social 





induced social abnormalities diminished when glutamate release was inhibited, 
demonstrating the contingency of the relationship between glutamate and analogous 
phenotypes of SZ (Moghaddam and Adams 1998).  Studies in awake animals showed that 
NMDAR antagonism resulted in increased glutamate neurotransmission mediated by 
other glutamatergic receptors such as AMPA receptors (Lorrain et al. 2003). fMRI 
studies in humans also demonstrated increased activity in the prefrontal cortex following 
exposure to NMDAR antagonists (Breier et al. 1997). Elevated levels of glutamate can 
produce excitotoxicity which leads to increased neuronal death and apoptosis (Bogaert 
2010). They can also disrupt connections between cortical and limbic layers resulting in 
compromised regulation of different circuits (Paz et al. 2008) Thus, analysis of glutamate 
levels may help gauge the effect of the GCPII mutation and offer insight on the viability 
of this mouse model. 
Magnetic Resonance (Kolodny Personal Communications 2013, Hashemi 
2004) 
MRI, DTI and MRS utilize the behavior of nuclei subjected to a magnetic field to render 
images, diffusion properties and spectra of proton-containing molecules such as water 
and metabolites, respectively. This thesis exploits the activity of hydrogen protons 
because of their relevance to biological systems and their relative abundance in both 
water and fat (Huang 2012). Hydrogen protons are within the subset of nuclear magnetic 
resonance (NMR) active nuclei because they have an odd number of protons: one.  
Nuclei are NMR active by virtue of unpaired protons or neutrons leading them to have 
non-zero spin quantum numbers (I).  Nuclei with nonzero quantum numbers have a 





quantum number determines the number of different energy levels nuclei can attain in the 
presence a magnetic field, in accordance with the following relationship.  
               # Energy Levels= 2(I) + 1 
Hydrogen nuclei have a spin quantum number of ½ and thereby two energy levels. The 
lower energy state occurs when magnetic moment aligns with external static magnetic 
field (B0) and higher energy state when the magnetic moment opposes B0. The net 
magnetization vector of the magnetic moments aligns with the external magnetic field 
because the lower energy state is more favorable. According to the classical model of 
magnetic resonance, as the magnetic moment aligns with or against the external magnetic 
field, it begins to precess about the external field in response to its force, much like a 
spinning top in response to gravity (Larmor Precession). The velocity or rate at which it 
precesses is the Larmor or resonance frequency of the nucleus. This resonance frequency 
(ω0) is determined by the strength of the magnetic field (B0) and the inherent 
gyromagnetic ratio (ɣ) of the nucleus, in accordance with the following relationship.  
       ω0 = ɣ B0  
The resonance frequency of hydrogen nuclei in a magnetic field strength of 9.4 Tesla is 
400 MHz. 
Radiofrequency coils are composed of loops of wires that function to both transmit an 
excitation pulse to a sample and receive the signal induced by changes in the magnetic 
properties of nuclei. The static magnetic field, B0, and initial net magnetization lie along 






Fig. 4. Net magnetization of magnetic moments align with the static magnetic field along the 
principal Z axis (Hashemi 2004). 
When the magnetic moments are subjected solely to the static B0 of 9.4 Tesla, their net 
magnetization lies along the z axis because they are out phase with one another, causing 
the x and y components of each magnetic moment to cancel. Magnetic moments can be 
said to project onto the x, y or z axes. In this initial condition, no signal can be obtained 
because the magnetic moments are neither projecting on the x nor on the y axis. Signal 
can only be detected within the plane the RF coil receiver lies in, which is the x-y plane. 
Only the projections of the magnetic moment in this plane can induce current within the 
coil and thereby manifest as a signal.  
In order for these magnetic moments to project into the x and y directions, they must be 
subjected to a second, weaker magnetic field, B1, perpendicular to B0. A radiofrequency 
(RF) coil delivers an RF pulse tuned to the resonance frequency of the nuclei, producing 
B1 and causing the alignments of the magnetic moments to rotate from the z axis to 
alignment with the x-y plane. The extent of movement the magnetization towards the x-y 
plane is described by the flip angle, determined by the gyromagnetic ratio and RF pulse 
duration and strength. Transverse magnetization (in the x-y plane) results when nuclei 






Fig. 5. Magnetic moments absorb energy from RF pulse excitation and move to the transverse plane 
(Hashemi 2004). 
Once in the x-y or transverse plane, nuclei precess about the z-axis in the x-y plane with 
their characteristic Larmor frequency.  
After transverse magnetization is achieved, the RF pulse is turned off leaving the 
magnetic moments solely subject to the static magnetic field, B0. The moments begin to 
dephase in the x-y plane and relax back towards their initial net magnetization with B0 in 
a time-dependent manner. T2 is the time constant that describes the dephasing of the 
magnetic moments, otherwise referred to as transverse relaxation, specifically the time 
when 63% of the phase coherence is lost. Magnetic moments are also sensitive to 
magnetic field inhomogeneities and the interaction with other nuclei. This is incorporated 
into the T2* decay time constant but neglected in T2. The final time constant, T1, 
describes the relaxation of moments towards the z axis, otherwise referred to as 
longitudinal recovery, specifically when 63% of the initial net magnetization is 
recovered.  
As the magnetic moments dephase and relax, their projection onto the x-y plane 
diminishes leading to a decrease in the detected signal. Changes in the x and y 





detected signal. The decay of the signal is referred to as the free induction decay or FID. 
In order to obtain spectrum for MRS or MRI, this FID is fourier transformed. 
Magnetic Resonance Spectroscopy (MRS) 
MRS is used in this study to probe levels of relevant metabolites. Hydrogen nuclei or 
protons in different molecules are exposed to magnetic fields distorted due to the 
electrons surrounding them. These distortions can either enhance or oppose the effect of 
the static magnetic field, B0, and are dependent on the electron density surrounding the 
proton (σ). Ultimately, this culminates in an effective magnetic field, Beff, for the nucleus 
which is determined by the following relationship.  
   Beff = B0 (1- σ) 
Nuclei, in our case protons, absorb different amounts of energy according to their 
effective magnetic fields. When the electron density surrounding the nucleus opposes B0, 
the nucleus is shielded from the external force. Alternatively, if the electron density of the 
nucleus aligns with the magnetic field, it is deshielded. Each proton in each type of 
molecule has a corresponding peak on a spectrum located along the x-axis signifying its 






Fig. 6. Proton NMR (1H-MR) spectrum including labeled peaks representative of metabolites with 
different chemical shifts (Huang 2012) 
These peaks are found upfield if the hydrogen nucleus is shielded or downfield if it is 
deshielded. The amount or concentration of a specific molecule is proportional to the area 
under the peak. Within any experiment, the chemical shifts of molecules must be 
compared to a reference frequency. Here the NAA+NAAG peak is used because it is both 
easily identifiable and clearly resolved in the mouse brain. 
 It is imperative to have the least field inhomogeneity when obtaining a 
spectrum. Shim coils throughout the magnet are adjusted, either manually or 
automatically to homogenize the magnetic field. FASTMAP pulse sequence is used to 
adjust first and second order shims. 
Pulse Sequences 
A pulse sequence refers to both the order and components of an imaging or spectroscopy 
protocol. In general, pulse sequences include components which prepare the sample by 
suppressing certain signals from water, fat or outer volume, excite the sample and read 
out the signal. They detail the amount of times the sample is excited (repetitions), the 





between the excitation and the readout of the signal or echo, (echo time; TE). When 
obtaining an NMR spectrum, the Point Resolved Spectroscopy (PRESS) pulse sequence, 
which consists of three RF excitation pulses in the x, y and z axes with flip angles 90, 180 
and 180 respectively, is used along with gradient pulses (Fig. 7.). 
                   
 
Fig. 7. PRESS pulse sequence demonstrating timing of VAPOR water suppresion, outer volume 
supression, excitation and signal readout (Bruker Biospin-Measurement Methods 2006). 
Gradients function to further distinguish signals by changing the field strength along each 
principal axis. RF pulses are applied with gradient pulses so that all three (horizontal, 
coronal and sagittal) planes are sampled. The final signal echo will be the composite of 
where all of these planes intersect, rendering a single voxel (Yerby 2005). In this thesis, 
PRESS is used to obtain information from a voxel placed over the hippocampus and 





would overwhelm that from the relatively small concentration of metabolites and outer 
volume suppression to negate signal from the area outside the voxel (Gujar et al., 2005). 
Interest in the hippocampus is rooted in its role in learning and memory, an area that 
patients with SZ have exhibited deficits in. Prevalent findings have also found 
hippocampal abnormalities in those with SZ (Shenton et al. 2001)  
Many of the metabolites of interest are separated from one another along a spectrum 
because each contains protons subject to different effective magnetic fields, leading to 
various chemical shifts as the spectrum. Table 2 below includes the chemical structures, 
predicted chemical shifts and representative experimental spectra for each brain 






























































































Magnetic Resonance Imaging (MRI) 
MRI utilizes magnetic field gradients and a spin echo pulse sequence allowing for either 
T1 or T2 weighted images determined by parameter values for TE and TR (Fig.9.). 
 
Fig. 8. Spin echo pulse sequence illustrating timing of RF pulse excitation, the slice selection gradient 
(SLICE) and phase encoding gradient (PHASE) (BITC 2005). 
A spin echo pulse sequence includes an initial excitation 90
o
 RF pulse followed by a 180
o
 
refocusing pulse in order to rephase the magnetic moments which had begun to relax and 
dephase. This rephasing of the magnetic moments maximizes the subsequent signal 
(echo) that will be detected by the radiofrequency coil. MRI obtains signal predominantly 
from water molecules. T1 and T2 weighted images render these tissue-specific signals 
distinctively. Whereas a T1 weighted image presents fat as bright and water as dark, a T2 
weighted image presents water as bright and fat as dark. T2 weighted images are obtained 
for anatomical data by manually adjusting the TE and TR of the pulse sequence. In order 
to obtain T2-weighted contrast characteristic of T2 weighted images, both a long TE and 





obtain T1-weighted images. 
By compartmentalizing the brain into three subtypes of tissue, cerebrospinal fluid (CSF), 
gray matter and white matter, it is evident how the behavior of water varies according to 
the tissue type. The more water present in the tissue, the longer it takes for the magnetic 
moments to dephase in the x-y plane and the slower the longitudinal relaxation. T1 and 
T2 are properties inherent to the tissue (Fig. 9.). 
 
Fig. 9. Longitudinal relaxation (T1) on left and dephasing in x-y plane (T2) on right for gray matter 
(GM), white matter (WM) ad cerebrospinal fluid (CSF) (Hashemi 2004). 
Cerebrospinal fluid thereby has the longest T2 and white matter, being comprised of fat 
cells, has the shortest. The amount of time following the radiofrequency pulse is crucial 
in determining which tissue will have greater signal intensity. If the TE is short, signal 
intensity from fat will be greater than that of water but if it is long, as in our case, water 
will be bright and fat dark. 
Another necessary component in MRI is spatial differentiation. Unlike MRS, it is crucial 
to determine where specific signal is emanating from in order to visualize a spatial map 
of the brain. This is achieved by encoding both the frequency and phase of signal within a 
specific slice. Pulse sequences attain greater complexity when spatial dimensions need to 
be included by incorporating gradient coils. Frequency, phase and position of magnetic 
moments are varied and measured with the use of three gradient coils (Gx, Gy, Gz).  In 





different positions along the z-axis (see below). The slice select gradient Gz alters the 
static magnetic field along this axis; therefore nuclei at different positions or within 
different slices resonate at unique Larmor frequencies. The frequency of the RF pulse is 
fine tuned to this Larmor frequency so that signal is solely obtained from the nuclei 
within the slice. Signal from the nuclei above or below the slice is effectively silenced. 
Within the slice, both phase and frequency must be encoded in order to render a spatial 
map of the sample. The frequency encoding gradient, Gx alters magnetic field strength 
along the x axis imparting distinct frequencies to magnetic moments. Gy, the phase 
encoding gradient alters magnetic field strength along the y axis and thereby varies the 
phase of magnetic moments within a specific position. Each gradient is applied at specific 
times relative to RF pulse excitations and signal readout (Fig. 10.). 
 
Fig. 10. Application and duration of three gradients in spin echo pulse sequence: slice selection 
gradient (Gz), phase encoding gradient (Gy) and frequency encoding gradient (Gx) (Hashemi 2004). 
The signal encoding phase and frequency is slice specific and stored as an individual data 
set within k-space, which essentially consists of the raw data from the MRI signal. These 





of an MR image.  
MRI is used to probe brain structures previously implicated in the progression of 





 and lateral ventricles. A predominant finding in MRI studies on humans with SZ, 
as mentioned above, has been enlarged ventricles, both third and lateral. Abnormalities 
have also been exhibited in the hippocampus, frontal and parietal lobes, and cerebellum 





and lateral ventricles along with hippocampal asymmetry have previously been found in 
GCPII
+/-
 mice, consistent with typical findings in those with SZ (Huang 2012). 
Diffusion Tensor Imaging (DTI) 
Finally, implementation of the diffusion tensor imaging (DTI) protocol will enable the 
exploration of potential abnormalities in the white matter tracts of the GCPII
+/-
  mouse 
model.  DTI is rooted in the diffusion of water, which can be defined as thermally driven 
movement throughout the brain also known as Brownian motion (Beaulieu 2002). 
Different types of tissues subject water molecules to different degrees of obstruction.  In 
cerebrospinal fluid, water is considered isotropic because it is allowed to move in all 
directions unhindered, but in white matter it is said to be anisotropic because its 








Fig. 11. Water diffusion in isotropic and anisotropic environments. Molecules experience very little 
obstruction in CSF filled ventricles and can therefore move in any direction (A) in this isotropic 
environment. Molecules are restricted to move longitudinally within an axon (B)  and are highly 
anisotropic within many axons as in white matter tracts or bundles (C) (Gold et al. 2012). 
DTI is the composite of diffusion information acquired from multiple diffusion weighted 
images (DWI) along several directions (Alexander et al. 2007). A single shot echo planar 
image (EPI) spin echo pulse sequence is used to acquire each DWI (Fig. 12.). 
 
Fig. 12. Single shot EPI based pulse sequence for Diffusion Weighted Image. Gradients (Gx, Gy, Gz) 
are applied prior to and following the refocusing 180° RF pulse. Multiple echoes are obtained from 





This pulse sequence demonstrates how diffusion information is obtained. Through the 
combination and variation of three gradients along the principal axes, water diffusion can 
be tracked along different directions. The diffusion coefficient represents the diffusion 
along the determined direction by the gradient (Maas 2003). The gradients are applied 
prior to and following the refocusing RF pulse and function to first dephase and then 
rephase the magnetic moments (Alexander et al. 2007). In stationary tissue, the resulting 
signal will not be attenuated because the second gradient pulse will ideally undo the 
effects of the first on the magnetic moments. However, because water molecules move 
during the time gap between the two gradient pulses, they experience a different gradient 
strength. This leads to incomplete rephasing and ultimate loss of signal. The diffusion 
coefficient (D) can be calculated from the loss of signal intensity using the following 
relationship (Maas 2003).  
                                                       
The b factor included in the relationship represents the strength, shape and duration of the 
gradient pulses that are applied (Maas 2003). A given b value is set (786.73 sec/mm
2
) 
that determines the extent of dephasing induced in the sample. I0 is the measured signal 
when the b value is 0, when there is no application of gradients, while I is the observed 
signal once the gradients are applied. A baseline image (b=0) is necessary for any DTI 
dataset. DWI data are obtained along thirty gradient directions. Diffusion coefficients 
calculated from these directional samplings comprise the diffusion tensor (LeBihan et al. 
2001). The diffusion tensor itself consists of diffusion values along the principal axes of 





tensor can be visualized as a 3x3 matrix or as an ellipsoid (Fig. 13.)     
 
Fig. 13. Representation of the Diffusion Tensor. 3x3 Matrix (A), ellipsoid (B, C). Eigenvalues and 
eigenvectors adhere to ellipsodial radii along major (1) and minor (2,3) axes. (Thomalla et al. 2004). 
The tensor can be used to determine the direction of diffusion along (eigenvectors, ε1 ε2 
ε3) and value of diffusivity (eigenvalues, 1   2  3) for a given three dimensional tract of 
the sample. Eigenvalues can be used to determine the fractional anisotropy (FA) of a 
given white matter tract. FA expresses the extent that water diffusion is restricted by cell 
cytostructure. Healthy white matter possess a high degree of organization and integrity 
leading to high FA values while damaged white matter sustaining diminished axonal 
density and homogeneity produces lower FA values. FA of CSF is standardized at a value 
of 0. The diagonal elements of the tensor, Dxx Dyy and Dzz, can be used to determine 
the mean diffusivity (MD) of the sample.  MD is equal to the average of the diffusion 
along the principal axes of the instrument and therefore represents the overall diffusion of 
water independent of direction. MD values are shown to be indirectly proportional to FA. 
Greater MD in white matter can signify demyelination or breakdown of neural 
architecture (Ciccarelli et al. 2003). DTI experiments are being planned to assess the MD 
and FA of white matter tracts and bundles shown to be damaged in the GCPII
+/-
 mouse 
model for SZ including cingulum bundle, corpus callosum, internal capsule, fornix, 
arcuate fasciculus and superior occipito frontal fasciculi (Kubicki et al. 2005). A majority 





within the limbic system, regions which have been formerly implicated in the pathology 
of the disorder.  
 The goal of this thesis is to further investigate the GCPII
+/-
 mice as a 
model for the NMDAR dysfunction endophenotype of schizophrenia and ultimately to 
determine the viability of the model through assessment with MRI, MRS and a 
behavioral paradigm. Furthermore, this thesis includes the laying of the groundwork for 
an updated GCPII+/- mouse model and the implementation of DTI as a tool to expand the 
examination of structural abnormalities. Incorporation of epigenetic dysregulation is 
motivated in the hope of better mirroring the progression of SZ and exploring the 
influence of gene expression, and DTI allows for probing of white matter structures 

















Materials and Methods 
Animal Model 
GCPII+/- mice served as a model for the NMDAR dysfunction endophenotype of 
schizophrenia in the initial experimental design of this thesis. These mice are 
heterozygous knockout mice for the folate hydrolase 1 gene responsible for the 
production of the enzyme glutamatecarboxypeptidase II. GCPII+/- (HET) mice were 
tested alongside control wild type (WT) C57B1/6J mice. The original GCPII+/- colony 
was founded at McLean Hospital (Coyle, Belmont, MA). All mice were bred and housed 
in the Wellesley College Animal Facility where they were subject to a 12 hour light/12 
hour dark cycle and a temperature of 21 ± 1°C. Food and water was available ad libitum. 
At postnatal day (PND) 21 mice were weaned and divided into cages according to litter 
and gender. Ear clipping was used as method of identification for imaging and behavioral 
experiments. Mouse Genotype (Carlsbad, CA) was responsible for genotyping portion of 
the study. 
Behavioral testing was conducted between PND 114 and 117 in a chambered social 
apparatus. MRI and MRS portions of the study were conducted on PND 35/36, 49/50 and 
63/64 using a 9.4 T Bruker Avance DRX 400 MHz vertical bore NMR spectrometer with 
a MicroMouse 2.5 imaging accessory (Bruker Biospin, Billerica, MA). Bruker 
ParaVision 4.0 and Bruker Topspin 1.5 software (Ettlingen, Germany) on a Linux system 
were used to design and implement scan protocols, obtain data and analyze spectra. MRI 
and DTI data were analyzed using Analyze 10.0 image analysis software on a Lenovo PC 
and ParaVision 4.0 ROI tool, respectively. Diffusion Tensor Imaging (DTI) protocol was 






The social test apparatus, modeled on a prior study on social withdrawal of autistic mice 
(Moy et al., 2004), was constructed with Plexiglas (Wellesley College Machinist, 
Estuardo Rodas). The apparatus contains three chambers each 20 cm wide, 22 cm high 
and 40.5 cm long. The lateral chambers were blocked off from central chambers by 





Fig. 14. Camera view of social test apparatus during habituation phase. Wire cages 
and blocked doors are labeled. 
Overturned 4x4x4.25 inch (width x depth x height) steel cages were placed in each of the 
side chambers (Galaxy Cup, Spectrum Diversified Designs, Inc., Streetsboro OH). 
Behavioral testing consists of 2 phases: habituation and sociability. During the 
habituation phase, the test mouse was introduced into the central chamber with the lateral 
chambers blocked off, and allowed to explore for ten minutes. After ten minutes, the test 
mouse was removed from the apparatus and placed in a temporary cage on the opposite 
side of the testing room while the sliding doors were removed and the stranger mouse 





chambers. The test mouse was then reintroduced to the center chamber, commencing the 
sociability phase. The test mouse’s exploratory behavior was videotaped for 10 minutes 
with a Sony DCR-SX85 digital video camera recorder atop a tripod located 5 feet above 
and 0.5 feet away from apparatus. All trials were digitally stored and then transferred 
onto computer for analysis. 
Pre-Imaging Procedure 
Test mice were anesthetized in a Plexiglas chamber (Braintree Scientific, Inc., Braintree, 
MA) with 2% Isoflurane in oxygen flowing at a rate of 0.2 L/minute. Mice were 
subjected to anesthesia for a period of approximately ten minutes until sleep was induced 
within the chamber, confirmed by the absence of a reflex to a foot pinch. They were then 
transferred to the Bruker Avance Mouse micro-imaging probe. Mice were secured in the 
probe with 3M Micropore
TM




Fig. 15. Aerial view of mouse bed. Labeled sensor pad, bite bar and tubing responsible 
for inflow and outflow of isoflurane/O2 gas mixture. 
 
Exposure to anesthesia was sustained when the mouse was in the probe by means of 
tubing connected to mouse bed. An exhaust tube was connected to both the chamber and 
the probe in order to contain the contaminated oxygen, and transfer it to a F/AIR 
Scavenger activated charcoal filter (Paragonmed, Coral Springs, FL). Temperature of the 





drops in mouse body temperature. Respiratory rate was monitored during imaging session 
by a respiration sensor pad located beneath the mouse’s abdomen on the mouse bed. 
Sensor pad signals were received by Bruker BioTrig Triggering and Monitory acquisition 
and command modules, and subsequently visualized onto a C840 Latitude laptop 
computer with Bruker Biotrig software. Isoflurane levels were modulated using a VIP 
Veterinary Vaporizer (Colonial Medical Supply Co., Franconia, NH) in order to maintain 
a respiratory rate within the bounds of 50 to 100 breaths per minute. 
Magnetic Resonance Imaging 
The imaging probe was first tuned to the resonance frequency of the hydrogen protons at 
400 MHz and matched to 50 Ω impedance in order to obtain the highest signal to noise 
ratio for both the imaging and spectroscopy components of the study. A 
SINGLEPULSE_1H scan (TR=2665.65 ms, reps=200, averages=1) was used to manually 
shim and homogenize the magnetic field. To confirm the proper positioning of the test 
mouse a RARE_tripilot pulse sequence was run (TE=12.5 ms, TR= 2000.000 ms, rare 
factor=8, matrix size= 128 x 128, averages=1) rendering 3 slices of the mouse brain; 
sagittal, coronal and horizontal. The entirety of the mouse brain from the cerebellum 
through the frontal lobe must be within the bounds of the radiofrequency coil in order for 
a complete set of anatomical images. Anatomical images were obtained using a 
RARE_8_bas T2 weighted pulse sequence (TE=15 ms, TR= 3109 ms, Tx0 ~15 dB, 
Tx1~5.2 dB, FOV=2.56 cm
2
, averages=16) rendering 24 0.7mm thick coronal slices from 






Fig. 16. Representative sample of coronal slices obtained with RARE_8_base pulse sequence. Only 15 
slices are shown; tracing of internal and whole structures was accomplished using Analyze 10.0 post data 
collection. 
Magnetic Resonance Spectroscopy 
Metabolite levels of the neurotransmitters and neurochemicals creatine, 
glutamate+glutamine, N-acetylaspartate/N-acetylaspartylglutamate, taurine and choline 
were determined from a spectrum of the medial region of the hippocampus. A more 
encompassing region was first delineated with a 4x4x4 mm
3
 cuboid voxel of the internal 
structures on a RARE_8_bas coronal slice (Fig. 17a.). The magnetic field was shimmed 
over this region with a fastmap_4mm scan. Following shimming, the dimensions of the 
cuboid voxel were diminished to 4x2x3 mm
3 
to closely fit the hippocampus (Fig. 17b.). 
 
Fig. 17. A. 4x4x4 mm
3
 cuboid voxel over hippocampus along with lateral and third ventricles. B. 
4x2x3 mm
3 






Sufficient suppression of the water signal is necessary for greater resolution of metabolite 
levels. The PRESS_waterline pulse sequence (TE=20 ms, TR= 2000 ms, averages=8) 
was applied in order to observe a water peak. Bruker TopSpin 1.5 software was used to 
analyze the obtained water spectrum. A water peak width less than 25 Hz ensured that the 
homogeneity of the magnetic field was adequate. The PRESS_1H pulse sequence (TE=20 
ms, TR=2000 ms, Tx0~150, Tx1~9.4, averages=800) was then used to acquire a 
spectrum of metabolites. The sequence also reduced signal from water in the tissue and 
the signal from surrounding tissues. 
Diffusion Tensor Imaging 
DTI necessitates a modified preparatory fastmap_4mm scan with a 5x5x5 mm
3
 voxel to 
create maximal field homogeneity over internal brain structures. In preliminary 
experiments designed to learn how to acquire DTI images a RARE_8_bas pulse sequence 
was used to collect anatomical information. EPI_diffusion_tensor was implemented to 
obtain diffusion weighted images (TE=33 ms, TR= 2850 ms, matrix size= 128 x 128, 
slice thickness=0.8 mm, slices= 19, FOV=2.00 cm
2
, b= 786.73 s/mm
2
, diffusion 
directions = 30, A0 images=5, averages=10, Tx0 ~7dB, Tx1~0 dB). Nineteen slices of 
the brain from the cerebellum to the frontal lobe were obtained from this scan. In order to 
acquire images allowing calculation of the relevant parameters, fractional anisotropy 
(FA) and mean diffusivity (MD) of different white matter tracts, a post-processing macro 
was applied, DTI_PROC_TENSOR. This renders 4 different types of images: Fractional 
Anisotropy, Diffusion Tensor components, eigenvalue images and components of 
eigenvectors. Paravision 4.0 provides a DTI VISUALIZATION tool to construct color 






Results for male and female mice were analyzed separately.  
Behavioral 
Digital recordings were observed on either a Lenovo computer or Asus Laptop. 
Timestamps of the test mouse’s entry and exit from each chamber were recorded from the 
habituation phase over a duration of 10 minutes (600 seconds). The amount of time spent 
in either the empty chamber or the stranger chamber with the enclosed WT breeder 
mouse was summed and averaged for each of the four groups of mice: WT males, WT 
females, HET males, and HET females. 
MRI  
Anatomical MR images of mouse brain were analyzed using Analyze 10.0 software 
(Mayo Clinic, Rochester, MN). Whole brain and internal structures: cerebellum, third 
ventricle, fourth ventricle, left and right lateral ventricles and left and right hippocampus  
were traced using a Wacom Cintiq 12WX tablet display (Wacom Co., Ltd., Tokyo, 
Japan). Volumetric measurements were determined by employing the Sample Images 
tool of the ROI interface which used both the 2-dimensional trace and 0.7 mm slice 
thickness for volume calculations. Cerebellum and internal structures were traced 
consistently by one lab member while whole brain was traced consistently by another. 
MRS 
Bruker TopSpin 1.5 software was used to analyze the metabolite MR spectra. The 
signal/noise ratio was improved with the application of a linewidth function of 10 Hz. 
Spectra were then calibrated to the marker N-acetylaspartate/N-acetylaspartylglutamate 





under the peaks and thereby the levels of the metabolite with the creatine peak at 3.0 ppm 
as an internal standard. The neurometabolities of interest were choline, 
glutamate/glutamine, N-acetylaspartate/N-acetylaspartylglutamate and taurine. 
Statistical Analyses 
Statistical tests were conducted separately for males and females. 
Social Preference 
Student’s t-tests were used to analyze the amount of time spent in stranger and empty 
chamber by each genotype group (WT and HET). A paired one-tailed t-test assuming 
equal variance was conducted for HET mice while a paired two-tailed t-test assuming 
equal variance was conducted for WT mice. Analyses were conducted in Microsoft Excel 
and p < 0.05 was considered significant. 
MRI and MRS 
Volume of brain structures and metabolite levels expressed as means were analyzed with 
repeated measures ANOVAs using genotype as the between group factor with age as the 
repeated measures. Post hoc Tukey’s HSD analyses were used to determine the 
differences between genotype groups as well as between time points. Analyses were 
conducted in JMP and p < 0.05 was considered significant.  
Multivariate correlation analysis was also conducted in JMP with pairwise correlation to 
determine p value for relationship between choline (cho/Cr) and glutamate+glutamine 







Results and Discussion 
Behavioral Paradigm 
Social withdrawal of both wild-type (WT) and GCPII+/- (HET) mice was assessed at a 
single time point between postnatal day (PND) 114 and 117, approximately  4 months of 
age. Wild-type mice are expected to exhibit a normal social preference by spending 
significantly more time in the chamber with the stranger mouse. Alternatively, GCPII+/- 
or HET mice are expected to exhibit social withdrawal by not spending significantly 
more time with the stranger mouse. Preliminary behavioral tests conducted on mice 
ranging from PND 60 to PND 180 demonstrated no social abnormality in HET mice. 
This was attributed both to testing at premature ages and the wide range in age. In order 
to offset these confounding variables, a four day time window was designated as the 
testing period for sociability. Data from male and female mice were analyzed separately 
in these tests due to the sex differences formerly observed in the GCPII
+/-
 mouse model 
(Huang 2012). 
 Both male and female control WT mice (males: n=19; females: n=18) 
exhibited normal preference by spending significantly more time in the chamber with the 
stranger mouse (Student’s t-test: males: p <0.05; females: p < 0.01) while both male and 
female HET mice (males: n=13; females: n=8) showed no preference for the chamber 
with the stranger mouse (Student’s t-test: males: p = .12; females: p = .67) thereby 






These findings mirror those from preliminary studies on social interaction in GCPII+/- 
mice (Han et al. 2009) and support the hypothesis that the GCPII mutation leads to 
NMDAR dysfunction. Findings agree with those exhibited in mouse models of direct 
NMDAR antagonism. An earlier study that administered the NMDAR antagonist, MK-
Fig. 18. Male and female GCPII
+/-
 (HET) mice exhibit social withdrawal in comparison to 
control (WT) male and female mice. Comparing amount of time mouse spent in the empty side 
chamber (Empty) with that spent in the chamber with stranger mouse (Stranger). Average values 






801, to rats found that it induced social withdrawal (Rung et al. 2005). A different study 
modeled NMDAR dysfunction with genetically modified mice that only expressed 5-10% 
of the normal levels of a subunit of the NMDA receptor complex, NR1, (Mohn et al. 
1999) and also found that these mice exhibited social withdrawal. More importantly, this 
study also demonstrated that clozapine, the leading antipsychotic for schizophrenia, 
attenuated the social deficit in these mice. Withdrawal from social interaction is a core 
negative symptom of schizophrenia and this observed social deficit suggest that the 
GCPII+/- knockout mice can present with phenotypes relevant to schizophrenia, therefore 
attesting to the model’s value. 
Magnetic Resonance Spectroscopy and Magnetic Resonance Imaging 
Neurometabolite levels of choline, glutamate and Glutamine (Glx), N-acetylaspartate and 
N-acetylaspartylglutamate (NAA+NAAG) and taurine (Tau) were assessed in both WT 
and HET mice at three time points following imaging: PND 35/36, PND 49/50 and PND 
63/64. Levels were normalized to the internal standard of creatine (Cr). Difficulties in 
resolving the peaks for N-acetylaspartate and N-acetylaspartylglutamate (NAA+NAAG) 
resulted in interpretation of the single observed peak as a composite of both metabolites. 
Such difficulties were also present between glutamate and glutamine (Glx) because of 
similarities in their chemical shifts. Both an upfield and downfield peak are present in 
spectra for glutamate. Here the downfield peak is used as the composite of glutamate and 
glutamine (glx) as glutamate (Fig. 6.). 
Volumes of the whole brain (WB), hippocampus (HP/WB), cerebellum (CB/WB), and 
third (3V/WB), fourth (4V/WB) and lateral ventricles (LV/WB) were measured at same 





were normalized to the volume of the whole brain. In order to probe structures for 
asymmetry, the left hippocampi (LH) and right hippocampi (RH) and left lateral 
ventricles (LLV) and right lateral ventricles (RLV) were measured separately and 
hippocampal asymmetry (LH/RH) and ventricular asymmetry (LLV/LRV) were 
determined. 
The data were analyzed by gender due to the sex differences previously observed in the 
GCPII
+/-
 (HET) mice (Huang 2012). Repeated measure ANOVAs were conducted to 
determine if the factors AGE or GENOTYPE had a significant effect on neurometabolite 
levels or volume and if there was a significant interaction between AGE and 














Females : Genotype Effect on Metabolite Levels 
Analyses found a significant effect of GENOTYPE on levels of glutamate and glutamine  
(Glx/Cr) [F(1,21) = .575, p <0.01], choline (Cho/Cr) [F(1,21) = .221, p <0.05]  and  N-
acetylaspartate +N-acetylaspartylglutamate (NAA+NAAG/Cr) [F(1,21) = 0.0183, p 
<0.05] in female mice.  GENOTYPE did not have a significant effect on levels of 
Taurine (Tau/Cr) in females. 
Glx/Cr levels were significantly higher in HET females  
HET females (n=8) exhibited higher levels of composite Glx than WT females (n=15) did 




Higher levels of glutamate may be a function of NMDAR dysfunction mediated by 
diminished levels of GCPII.  Initially the effects of pscyhomimetic drugs like PCP or 
LSD were interpreted as proof that hypoactive glutamatergic neurons were a fundamental 
Figure. 19. HET females have higher levels of glutamate and glutamine at PND 35/36 and 
49/50. Levels of glutamate normalized to creatine. Repeated measure ANOVAS and Tukey's HSD 








phenomenon in schizophrenia (SZ) (Paz et al. 2008). Diminished levels and activity of 
glutamate have been observed in the prefrontal cortex in a number of studies, but recently 
views concerning the underlying glutamatergic dysfunction have been called into 
question (Lutkenhoff et al. 2010; Paz et al. 2008).  
This recent change in views has been attributed to the failure of NMDAR therapeutic 
enhancement to alleviate symptoms of SZ (Carpenter and Thaker 2007; Paz et al. 2008) 
as well as findings of increased glutamate in the striatum and the prefrontal cortex in 
response to NMDAR antagonism via PCP or other psychomimetic drugs (Bustos et al. 
1992; Moghaddam et al. 1997, Paz et al. 2008). Such effects are suggested to result from 
the role that NMDARs have in the regulation and excitation of GABAergic interneurons. 
These interneurons, as previously mentioned, function to maintain the balance between 
excitation and inhibition and their compromised function can manifest in dysregulated 













Cho/Cr levels were significantly higher in HET females  
HET females exhibited higher levels of choline (Cho/Cr) than WT females did on PND 




Studies on choline levels in patients with SZ are not entirely conclusive. Some studies on 
the hippocampus of SZ patients observed decreased levels of choline (Maier et al. 1995; 
Maier et al. 1996, Fukuzako et al. 1995), while others detected greater levels of Cho 
when comparing patients with their unaffected twins and controls (Lutkenhoff et al. 
2010). Choline levels were also found to correlate positively with duration of untreated 
psychosis (Lutkenhoff et al. 2010). Choline is present in membrane phospholipids, and 
their increase can signify demyelination or breakdown of neuronal membranes (Théberge 
et al. 2003). Breakdown of membranes free lipids which are then NMR visible . 
(Milkevitch et al. 2005). Increases in NMR visible glycerophosphocholine, the choline-
Figure. 20. HET females have higher levels of choline at PND 49/50. Levels were 
normalized to creatine. Repeated measure ANOVAS and Tukey's HSD post hoc. Average 






containing membrane phospholipid, are attributed to increased phospholipase A2 activity 
which in turn is activated by glutamate and NMDA receptors (Milkevitch et al. 2004; 
Kim et al. 1995; Sandhya et al. 1998). For this reason, Théberge and his colleagues 
postulate that increased levels of choline could be indicative of hyperglutamatergic 
activity. Hyperglutamatergic activity causes excitoxicity of neurons leading to apoptosis 
and cell death (Bear 2006).  This hypothesis prompted multivariate correlation analysis 
on female mice (HET and WT). Analysis revealed a significant positive linear correlation 
between glutamate and choline on PND 49/50 in female mice (pearson product-moment 
correlation coefficient: 0.6898; p<0.001). Although this correlation does not affirm a 
causal relationship between glutamate and choline, it is significant to note that its 
presence coincides with significantly elevated levels of glx/cr and cho/cr in female HET 
mice. Since the correlation is present in both WT and HET females, these data may show 













NAA+NAAG/Cr levels were significantly lower in HET females 
HET females had significantly diminished levels of NAA+NAAG/Cr than WT females 
on PND 49/50 (p <0.05) (Fig. 21.). 
 
 
The ratio of NAA+NAAG to Glx was calculated and analyzed to further contextualize 
these differences. GENOTYPE was found to have a significant effect on this ratio 
[F(1,20) = .273, p <0.05]. 
Fig. 21.Female HET mice have lower levels of N-acetyl aspartate and N-acetylaspartylglutamate 
on PND 49/50. Levels of NAA + NAAG normalized to creatine. Repeated measure ANOVAS and 







NAA+NAAG/Glx ratio was significantly lower in HET females  
HET females exhibited significantly lower NAA+NAAG/Glx values than WT females 




Female mice exhibit a decreased NAA+NAAG/Glx (p<0.05) profile consistent with 
findings of elevated levels of glutamate and decreased levels of NAA+NAAG in other 
laboratories. Diminished levels of NAA have been reported in a number of proton MRS 
studies of the hippocampus in schizophrenics (Harrison 1999; Maier et al. 1995; 
Bertolino et al. 1996; Deicken et al. 1997, 1998). This phenomenon has been documented 
in drug-naïve, newly diagnosed and chronic schizophrenic patients (Bertolino 1998) as 
well as in adolescents, children and unaffected siblings (Bertolino A., Kumra S, Callicot 
J.H. et al. 1998). Female and male mice are sexually mature by 6-7 weeks therefore the 
middle time point used in this study can be considered analogous to adolescence in 
Fig. 22.Female HET mice have lower ratio value of NAA+NAAG/Glx at PND 49/50. Levels of all 
metabolites were normalized to creatine and measured NAA+NAAG was divided by measured Glx 
Repeated measure ANOVAS and Tukey's HSD posthoc. Average values shown ± SEM. Sample size 






human beings. NAA reduction has been linked to neuronal loss and dysfunction, tying it 
to structural abnormalities that have been observed in schizophrenia (Harrison 1999). 
Reduced levels of NAA also have been tied more specifically to NMDAR dysfunction by 
the documented effects of the receptor agonist phencyclidine (PCP) (Reynolds et al. 
2005). Although Reynolds et al. did not demonstrate reduced NAA levels in the 
hippocampus, it functioned to show the interaction effect of NAA levels and PCP 
administration in the striatum and temporal and frontal cortices that correlates with 
findings in SZ.  The GCPII+/- mutation may yield diminished levels of NAA because of 















Males: Genotype Effect on Metabolites 
Analyses found that GENOTYPE did not have a significant effect on neurometabolite 
levels; Glx/Cr, Cho/Cr, NAA+NAAG/Cr, Tau/Cr or on the NAA+NAAG/Glx ratio 
values in male mice. However, post hoc tests did find significant differences in 
NAA+NAAG/Glx levels between HET and WT males. 
NAA+NAAG/Glx ratio was significantly higher in HET males 
HET males exhibited increased ratio of NAA+NAAG/Glx on PND 49/50 (post hoc, p < 
0.05) (Fig. 23.). 
 
 
Findings of increased NAA+NAAG/Glx levels in HET males contrast with the reversed 
trend seen in HET females. Such an aberration can indicate either or both decreased 
glutamate and glutamine, as well as increased NAA+NAAG. These findings are 
Fig. 23.Male HET mice exhibit higher NAA+NAAG/Glx values at PND49/50 . Levels of all metabolites 
were normalized to creatine and measured NAA+NAAG was divided by measured Glx. Repeated measure 
ANOVAS and Tukey's HSD posthoc. Average values shown ± SEM. Sample size (n) included in genotype. 







inconsistent with the literature which suggests decreased levels of NAA and increased 
levels of glutamate (Bertolino1998). 
The absence of a significant genotype effect on neurometabolite levels juxtaposed the 
significant genotype effect on social preference seen in both male and female mice. Mice 
are behaviorally tested at approximately 16 weeks of age while imaging is conducted 
within 5 and 9 weeks of age.  The size of the imaging probe used restricts the period of 
observation because mice grow too large over time. Thus, the imaging period may be too 















Females: Genotype effect on brain structures 
Analyses found GENOTYPE had a significant effect on hippocampal (HP/WB) volume 
[F(1,22) = .261, p<0.05] in females. No significant effect was observed on ventricular 
(3V/WB, 4V/WB, LLV/WB, LRV/WB), cerebellar (CB/WB) or whole brain (WB) 
volumes. 
Hippocampal volume was slightly higher in HET females 
 HP/WB volume was not significantly different in HET females from WT females at any 
point but was slightly higher in female HETs at PND 49/50 (post hoc, p=0.053) and PND 
63/64 (post hoc, p =0.053) (Fig. 24.). 
 
The hippocampus is implicated in both the symptomology and pathophysiology of SZ. 
This structure is composed of two main classes of neurons, glutamatergic pyramidal 
neurons and GABAergic interneurons, making it an extremely relevant arena for 
adversities of SZ (Heckers and Konradi 2002). Studies have attributed reduced volume of 
Fig. 24.Female HET mice exhibit slightly higher hippocampal volume at PND49/50 and PND 
63/64 and both sets of female mice exhibit increase in hippocampal volume over time. Volumes 
were normalized to whole brain. Repeated measure ANOVAS and Tukey's HSD posthoc. Average 







the hippocampus to loss in the amount of white matter, specifically the GABAergic 
interneurons (Corter et al. 1987; Benes et al. 1998).Furthermore studies found depleted 
levels of GABA synthesis enzymes and upregulated GABA receptors in SZ patients. 
Such findings were attributed to underactivation of NMDAR (Benes et al. 1996, 1997; 
Heckers et al. 2002). NMDA receptors play the unique role of activating these 
GABAergic interneurons, and their localized dysfunction in a subset of these GABAergic 

















Males: Genotype effect on brain structures 
Analyses found GENOTYPE had a significant effect on hippocampal asymmetry (ratio 
of left hippocampus to right hippocampus; LH/RH) [F(1,23)= .519, p<0.01] and on right 
hippocampal volume (RH/WB) [F(1,23) = .186, p <0.05]. No significant effect was 
reported for ventricular (3V/WB, 4V/WB, LLV/WB, LRV/WB), cerebellar (CB/WB) or 
whole brain (WB) volume. 
Hippocampal asymmetry was significantly greater in HET males 
Male HET mice had significantly greater hippocampal asymmetry compared to WT 





Fig. 25.Male HET mice exhibit higher hippocampal asymmetry at PND 49/50. Volumes were 
normalized to whole brain. Repeated measure ANOVAS and Tukey's HSD posthoc. Average values shown 







Right hippocampal volume was significantly lower in HET males 
HET males have significantly smaller RH/WB volume than WT males on PND 49/50 
(post hoc, p<0.05) (Fig. 26.) 
 
In this project neither male nor female mice exhibited a genotype effect on the volume of 
the third, fourth or lateral ventricles although ventricular enlargement is a major 
abnormality found in SZ. Shenton and his colleagues report that in about 80% of 55 
studies enlarged lateral ventricles were found, with a more exaggerated effect on the left 
(Shenton et al. 2001). Whereas lateralization of abnormalities is exhibited by both the 
hippocampus and lateral ventricles in SZ, neither male nor female mice exhibited a 
GENOTYPE effect on lateral ventricle asymmetry while HET males did exhibit 
hippocampal asymmetry. Hippocampal volume is found to be diminished in the majority 
of studies on SZ with more reduction seen in the left side (Shenton et al. 2001; 
Velakoulis et al. 1999). HP/WB volume deficits have also been recently utilized as 
Fig. 26.Male HET mice exhibit smaller right hippocampus at PND 49/50. Volumes were 
normalized to whole brain. Repeated measure ANOVAS and Tukey's HSD posthoc. Average values 







predictors in children at risk for developing SZ.  
 Female HET mice exhibited increased total hippocampal volume as 
opposed to findings of reduced hippocampi in the literature. The Male HET mice 
exhibited a significantly higher hippocampal L/R ratio at PND 49/50 consistent with 
lateralization of hippocampal reduction seen in SZ although the lateralization in GCPII+/- 
male mice is in the left as opposed to the right. The mutation is nevertheless correlated 
with bringing about an endophenotype mirroring what is seen SZ.  
 The cerebellum is a region of the brain traditionally important for 
motor control but due to the connections it sustains with limbic structures and cortical 
areas important for cognitive faculties, its role in cognitive function has been 
reconsidered. Studies on SZ have not found major abnormalities in the gray matter of the 
cerebellum but have shown trends of increased white matter (Levitt et al. 1999). 
Increased white matter has been linked to compromised circuitry intrinsic to the 
cerebellum, and leading to cognitive dysfunction characteristic of SZ (Schmahmann 
1996). As previously mentioned, however, no significant effects or differences were 










Females: Age Effect on brain metabolites 
Analyses reported AGE had a significant effect on NAA+NAAG/Glx ratios [F(2,19) = 
.465, p <0.05] and Tau/Cr levels [F(2,20)=0.508, p < 0.05]. AGE did not have a 
significant effect on Cho/Cr, Glx/Cr or NAA+NAAG/Cr levels. 
NAA+NAAG/Glx ratio values decrease over time in female mice 
NAA+NAAG/Glx ratio values were not significantly different between any time points, 
but were slightly higher on PND 49/50 compared to values on PND 63/64 (post hoc, 
p=0.09) (Fig. 22.). 
Tau/Cr levels significantly decreased over time in female mice 
Taurine levels were significantly lower on PND 49/50 and PND 63/64 than at PND 35/36 
(post hoc, p<0.05) (Fig. 27.). 
  
Fig. 27.Female mice exhibit lower levels of Taurine at PND 49/50 and PND 63/64 compared to 
PND 35/36. Levels of Taurine normalized to creatine. Repeated measure ANOVAS and Tukey's 
HSD posthoc. Average values shown ± SEM. Sample size (n) included in genotype. Letters denote 
significant differences between time points a, b p<0.01. 







 Decrease in taurine levels can suggest diminished maintenance of neurons and neuronal 
membranes. However, these findings can also be interpreted to reflect a decreased need 
for neuronal upkeep as the mice fully mature. Studies on those with SZ have found 
increased levels of taurine and have attributed them to a potential increased need for 
protection against oxidative stress (Shirayama et al. 2009). Genotype does not have a 






















Males: Age Effect on metabolites 
In male mice, AGE was found to have a significant effect on levels of Cho [F(2,13) = 
1.264, p <0.01] and NAA+NAAG[F(2,13) = 1.172, p<0.01] as well as on the 
NAA+NAAG/Glx ratio values [F(2,13) = 1.87, p <0.01]. 
Cho/Cr levels increased over time in male mice 
Cho levels were not significantly different between any time points but were slightly 
higher on PND 63/64 compared to PND 35/36 (post hoc, p  = 0.6) (Fig. 28.). 
  
Fig. 28. Male mice exhibit slight increase in Choline levels over time. Levels of Cho 
normalized to creatine. Repeated measure ANOVAS and Tukey's HSD posthoc. 







NAA+NAAG/Cr levels peak in male mice 
NAA+NAAG/Cr levels were significantly higher on PND 49/50 compared to PND 35/36  










Fig. 29. Male mice exhibit higher levels of N-acetylaspartate and N-acetylaspartylglutamate at 
PND 49/50 compared to PND 35/36 and PND 63/64. Levels of NAA +NAAG normalized to 
creatine. Repeated measure ANOVAS and Tukey's HSD posthoc. Average values shown ± SEM. 









NAA+NAAG/Glx ratio values peak in male mice 
NAA+NAAG/Glx ratio values were signifiantly higher on PND 49/50 compared to PND 











Fig. 30. Male mice exhibit higher levels of N-acetylaspartate and N-acetylaspartylglutamate at 
PND 49/50 compared to PND 35/36 and PND 63/64. Levels of all metabolites were normalized to 
creatine and measured NAA+NAAG was divided by measured Glx. Repeated measure ANOVAS and 
Tukey's HSD posthoc. Average values shown ± SEM. Sample size (n) included in genotype. Letters 






Females: Age Effect on brain structures 
Analyses found that AGE had a significant effect on hippocampal (HP/WB) 
[F(2,21)=.44, p<0.05] and lateral ventricle  (LAT/WB) volume [F(2,21) = .39, p <0.05]. 
AGE did not have a significant effect on the volume of other brain structures; cerebellar, 




 ventricle, and hippocampal 
asymmetry.  
Hippocampal volume increased over time in female mice 
Although HP/WB volume was not significantly different between time points, it was 
slightly greater on PND 63/64 compared to PND 35/36 (post hoc, p = 0.0635) (Fig. 24.). 
Lateral ventricular volume increased over time in female mice 
Similar to HP/WB, LAT/WB volume was not significantly differently between time 
points but exhibited higher HP/WB volume on PND 63/64 compared to PND 35/36 (post 
hoc, p = 0.06) ( Fig. 31.). 
 
 
Fig. 31. Female mice exhibit small increase in lateral ventricle volume over time. Volume 
were normalized to whole brain. Repeated measure ANOVAS and Tukey's HSD posthoc. 







Male: Age Effect on brain structures 
Analyses found that AGE had a significant effect on HP/WB volume [F(2,22) = .320, p 
<0.05]. AGE did not have a significant effect on the volume of other brain structures; 




 ventricle, lateral 
ventricle and hippocampal asymmetry. 
Hippocampal volume increased over time in male mice 
Although HP/WB volume was not significantly different between time points, it was 






Fig. 32. Male mice exhibit small increase in hippocampal volume over time. Volumes were 
normalized to whole brain. Repeated measure ANOVAS and Tukey's HSD posthoc. Average values 






Females: Genotype x Age Interaction  
Analyses reported did not find the interaction between GENOTYPE and AGE to have a 
significant effect on metabolites; Cho/Cr, Glx/Cr, NAA+NAAG/Cr, Tau/Cr or brain 
structures; CB/WB. 
Males: Genotype x Age Interaction 
Analyses found that the interaction between AGE and GENOTYPE had a significant 
effect on NAA+NAAG/Glx ratio values [F(2,13) = .616, p < 0.05].  The interaction 
between AGE x GENOTYPE was not significant on any other neurometabolites; Cho/Cr, 





 ventricle, whole brain, hippocampus, lateral ventricular 













NAA+NAAG/Glx ratio  peaks 
HET males had a significantly higher NAA+NAAG/Glx ratio on PND 49/50 in 
comparison to PND 35/36 and PND 63/64 in HET males (post hoc, p <0.01). WT males 
exhibited the same trend with the NAA+NAAG/Glx ratio peaking at PND 49/50 relative 
to PND 35/36 (post hoc, p = 0.3) and PND 63/64 (post hoc, p = 0.4) but differences were 




While genotype effects offer the best support for the viability of the GCPII mutation in 
eliciting SZ pathology, consideration of the different trends in structural volumes and 
metabolite levels between male and female mice can also provide evidence further 
linking the mutation with NMDAR dysfunction and ultimately SZ.  
Fig. 33. Male HET exhibit different trend in NAA+NAAG/Glx ratio values over time Levels 
of all metabolites were normalized to creatine and measured NAA+NAAG was divided by 
measured Glx.. Repeated measure ANOVAS and Tukey's HSD posthoc. Average values shown ± 
SEM. Sample size (n) included in genotype. Letters denote significant differences between time 







Sex Differences in SZ (Leung and Chue 2000) 
This final discussion section outlines the ways different findings for male vs. female mice 
are comparable with those in human studies, as well as the potential cause for this 
difference (see table 3). 
Table 3. Composite sex differences in MRI and MRS findings. 
  
A review of human studies reveals that males with SZ exhibit more structural 
abnormalities than schizophrenic females. Similarly, this project found that male HET 
mice exhibited significantly greater hippocampal asymmetry and lower right 
hippocampal volume compared to male WT mice. While female HET mice solely 
exhibited significantly higher total hippocampal volume compared to female WT mice. 
Lateralization of brain abnormalities, specifically in the hippocampus, is predominant in 
Effect Males Females 
Genotype 
Effect 
Higher NAA+NAAG/Glx at PND 
49/50 in HET males  
Greater hippocampal asymmetry at 
PND 49/50 in HET males 
Smaller right hippocampus at PND 
49/50 in HET males 
Lower NAA+NAAG and 
NAA+NAAG/Glx at PND 49/50 in 
HET females 
Greater hippocampal volume at PND 
49/50 and PND 63/64 in HET 
females 
Higher Glx at PND 35/36 and 49/50 in 
HET females 
Higher Cho at PND 49/50 in HET 
females 
 
Age Effect Slight increase in Cho over time 
Increased NAA+NAAG at PND 
49/50 
Slight increase in hippocampal 
volume over time 
Slight decrease in NAA+NAAG and 
Tau levels over time 
Slight increase in hippocampal and 




Higher NAA+NAAG/Glx in HET 
males at PND 49/50 
None on neurometabolites 





males with SZ and is correlated with greater impairments to language processing.  
Some studies have found that males with SZ perform poorer in learning and memory 
tasks compared to females with SZ. Here, male HET mice exhibit hippocampal 
asymmetry and reduced right hippocampus at the same time female HET mice exhibit 
enlarged total hippocampal volume. Brain asymmetry observed in healthy brains offers 
insight into differential development of SZ. Healthy female brains have higher gray 
matter to whole brain values in the hippocampus as well as other cortical and temporal 
lobe areas, which has been attributed to having a protective role against cell death. 
Schizophrenic male brains exhibit more reduction in both temporal lobe structures and 
enlarged lateral ventricles with lateralized reduction in the left hemisphere.  
Although male HET mice closely mirror these structural abnormalities, female HET mice 
sustain the bulk of abnormal neurometabolite levels relevant to the disorder. Studies have 
contended that SZ male brains exhibit reductions in N-acetylaspartate levels and 
elevations of choline levels. These neurochemical aberrations are instead observed in 
female GCPII
+/-
 (HET) mice. While male HET mice better model structural abnormalities 
relevant to SZ pathology, female HET mice may prove to be a better model for the 
neurochemical abnormalities characteristic of SZ.  
Age of onset is another characteristic of SZ that differs among sexes, with males 
experiencing onset earlier (ages 18 -25) than females (ages 25-35, 40). This project 
similarly found that age interacts with genotype differently in males vs. females. Male 
mice exhibited a significant GENOTYPE x AGE interaction on NAA+NAAG/Glx ratio 
values, while female mice did not. It is crucial to take the age of mice during testing into 





with mouse adolescence during times of sexual maturity and changing hormonal levels. 
The significance of hormones is evident from findings on females with SZ. 
Antipsychotics are observed to be more effective in reproductive females and higher 
doses are needed in post-menopause females. Treated females also improve faster and to 
a greater extent than treated males. Investigations into these differences have identified 
the class of hormones, estrogens as the culprit tipping the balance. The estrogen 
hypothesis of schizophrenia is centered on the fact that estrogens play an important role 
in neurodevelopment by regulating the organization and structure of circuits throughout 
maturation and maintain a preventative antipsychotic role. Males exhibit slower 
development of neuronal connections and prolonged axonal myelination which is 
attributed to greater testosterone levels as opposed to estrogen. 
Estrogens are postulated to bear an antipsychotic role because diminished levels are 
directly correlated with increased severity and presentation of symptoms. This is 
characteristic of the period of menopause. It is hypothesized that the increased rate of late 
age onset of SZ in females is due to decreased levels of estrogens resulting from 
menopause. Estrogens have been shown to modulate dopaminergic activity by regulating 
receptor affinity and synthesis, tying it to aberrant dopaminergic activity that is a marker 
for the disorder. Estrogens also facilitates synaptogenesis, more specifically that of 
excitatory connections including NMDAR and therefore is also connected to 
glutamatergic neurotransmission.  
Estrogens may be at the root of the sex differences in subject mice and may also explain 
the concentration of differences in HET females at PND 49/50. Neurometabolite levels 





attributed to a potential interaction with the GCPII mutation,   NMDAR dysfunction and 
estrogen levels resulting in compromised protection of neurochemistry. PND 49/50 is 
right at the cusp of sexual maturity and thus could be the time when estrogen levels have 
begun to rise (Mayer et al. 2010). Abnormalities may be present at PND 49/50 because 
estrogens are still increasing and they’re could be a latency for their effect. Following this 
time point, PND 49/50, estrogens are thought to be elevated to be at their highest, which 
could possibly explain why many of the neurochemical aberrations are normalized by the 
















Conclusions and Future Work 
The GCPII
+/-
 mouse model is a promising start to mirroring relevant and characteristic 
endophenotypes of schizophrenia. This project found that genotype had a significant 
effect on the volume of brain structures, neurometabolite levels and sociability. 
Hippocampal asymmetry and lateralized hippocampal reduction in male GCPII
+/-
 HET 
mice on PND 49/50 resonated with findings in males with SZ. Increased levels of choline 
coupled with decreased levels of N-acetylaspartate and N-acetylaspartylglutamate in 
female GCPII
+/-
 HET mice on PND 49/50 accurately reflect neurochemical abnormalities 
prevalent in SZ studies.  Social withdrawal in both male and female HET mice was also 
observed. However, genotype was not found to play a role in male neurometabolite levels 
and only a subtle role on female hippocampal volume. 
The incorporation of epigenetic dysregulation and diffusion tensor imaging (DTI) propels 
this project into the current sphere of schizophrenia research. More attention is being 
given to the interaction between genes and environment as playing a major role in the 
progression and development of this disorder. Probing of white matter with DTI offers a 
novel perspective into structural abnormalities that may be considered more relevant for 
NMDAR dysfunction and SZ pathology as opposed to gray matter. This can be argued 
because NMDA receptors sustain a role in the formation and maintenance of connections 
that comprise tracts and bundles of axons throughout the central nervous system. 
Assessment of the viability of these tracts can indicate if NMDAR are functioning 
properly.  
Future goals of this project will be to solidify the procedure for neonatal rodent surgeries 





blotting and in situ hybridization to confirm overexpression of the enzyme.  The extended 
mouse model incorporates this introduction of histone deacetylase enzyme 1 cDNA 
(HDAC1) via an adeno-associaed virus (AAV) on the day of birth. Both GCPII+/- and 
WT mice will undergo this procedure, along with sham injections to control for potential 
confounding errors, resulting in six experimental groups; HET/AAV, WT/AAV, 
HET/saline, WT/saline, HET and WT.  
The DTI procedure must also be utilized to collect and analyze data along with continued 
anatomical and behavioral assessments. A final goal for this project could be to 
incorporate a pre pulse inhibition task as a behavioral assessment due to the 
translatability of the findings from rodents to humans and the predominance of the deficit 
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Appendix A. Behavioral Experiments  
 This is a guide for the set-up, execution and analysis of behavioral 
testing on mice. Male and female mice are tested between postnatal day (PND) 114 and 
117. Testing is conducted in room L336 in the Wellesley College Animal Facilities. The 
social paradigm assesses the social preference of test mice by determining how much 
time they choose to spend in a space with a stranger mouse vs. an empty space. The 
behavioral apparatus has two side chambers, one of which will contain the stranger 
mouse. Experimenters are blind to the genotype of the mouse during testing. Anticipating 
the effect that the side of the stranger mouse can have on social preference, stranger 
chamber assignment should be requested from Pat Carey to verify that each side is 
equally assessed throughout all tests. 
1. Setup of the paradigm necessitates the use of a large cardboard box to enclose 
Plexiglas apparatus. Pictures below display Plexiglass apparatus alone however. 
2. Once the Plexiglas apparatus is placed inside the cardboard box, make sure to 
wipe down all surfaces with PPE Cleaning Towelettes (Fisherbrand).  
 ○ Check that vertical doors are blocking openings in central chamber 
and that cages are inverted with empty glass bottles placed on top as weights 





       
 
 
3. Set up of the Sony™ DCR-SX85 digital video camera video and tripod. Both 
camera and tripod should be located in Kolodny lab room, SCI 2XX. 
 ○ Adjust the DYNEX™ DX-TRP60 tripod to its maximum height and 
click in the video camera.  
 ○ Make sure that the camera is charged and the visual field 
encompasses whole apparatus. 
4. Bring the cages housing test mice and stranger mice into room. Prepare an empty 
cage with shavings and metal cover as intermittent housing between phases of 
test. Prepare record in lab notebook denoting mouse number, gender, ear clipping 
and side of stranger mouse. Write down these identifiers on a piece of paper that 
will later be videotaped prior to the testing session (example below).  
 
 







5. Habituation phase Set stopwatch to ten minutes and place test mouse in central 
chamber, record time period.  
 
6. After ten minutes remove test mouse and place into intermittent empty cage. 
7. Free one of the wire cages from the glass weight and place stranger mouse inside. 
Then flip the cage down onto the platform of its corresponding side chamber, 
returning glass bottle weight. 
8. Remove sliding doors; hit ‘record’ on camera and videotape paper with identifiers 





9. Sociability phase Now return the test mouse into test chamber and note time, 
allow for ten minutes of exploration. 
           
10. Hit ‘stop’ on camera and return test mouse to home cage. Replace sliding doors, 
remove glass bottle weight and bring wire cage containing stranger mouse to its 
corresponding cage and allow for mouse to climb out. 
 
Wipe down surface in between test mice but not in between habituation (number 
5) and sociability phase (number 7) for each mouse. Mice will usually urinate and 
defecate in central chamber and therefore cleaning this might negate their 
familiarity with the space. 
 
 Analysis of Behavioral data 
o Digital recording is stored on camera’s internal memory and should be 





be burnt onto current DVDs and therefore should be backed up onto 
external hard drive.  
o Object of analysis is to document amount of time mouse spends in 
each chamber. Time in central chamber is not important for data 
analysis but ensures accurate recording. Sample table of data is 
provided below.  
 
o Bolded numbers are to show that only the first ten minutes of video 
should be analyzed. First timestamp should correspond to moment test 
mouse is placed in center chamber. Asterisk (*) denotes which 
chamber stranger mouse is in.  
o  Calculate the total time each mouse spent in the stranger chamber* 
and the empty chamber. Determine the average time mice spent in 
each chamber for all four experimental groups; Female HET, Female 
WT, Male HET, Male WT.  
o Run Student’s T-test within each experimental group separately. 
Conduct paired one-tailed assuming equal variance for HET mice and 






Appendix B. Diffusion Tensor Imaging 
 This section provides a guide on how to manually shim the magnetic 
field prior to imaging and the post processing of DTI data. General instructions for 
running MRI instrument are found elsewhere. 
1. Tune and match your sample first. Once probe is placed and 1H cable is 
connected, go to spectrometer control tool window, click acquire and choose 
wobble.  
2. Now load the SINGLEPULSE_1H scan by going to ParaVision Scan control 
toolNew ScanB_Spectroscopy and choosing SINGPULSE_1H scan. 
3. To allow for a seamless adjustment over time, edit the number of reps in the scan 
to 200 by selecting scanclicking edit method in spectrometer control tool which 
will bring you to parameter window.  
4. Next, load shim file by going to Spectrometer control tool 
windowToolsShim ToolLoad from fileSteph4. 
5. Prior to hitting the traffic light icon, increase Tx0 Attenuator value to ~33.9. 
6. Scan is now running. To homogenize the magnetic field, you want to adjust the X, 
Y, Z and Z
2
 values. Object of shimming is to obtain a symmetrical water peak and 
a gradual free induction decay (shown below). 
7. Begin by adjusting the Z value to left followed by the Z2, X and Y. Repeat as 
necessary. 
8. Once shimming is completed, stop the scan and run RARE_Tripilot and 






9. Load EPI-diffusion-tensor scan by choosing New Scan and setting Location to 
B_DIFFUSION. 
10. Select scan and go to spectrometer control tooledit method set Echo Time to 
33 msec, and the repetition time to 2850 msec on first window.  
11. Click on radio button ‘expand’ next to Diffusion and make sure that diffusion 
experiment is set to DW_Tensor with 30 diffusion directions, 1 diffusion 
experiment per direction and 5 A0 images. Scroll down to change bandwith value 
to 786.73 s/mm
2 
next to B values per direction. 
12. Expand Standard in plane geometry interface and change Field of View (FOV) 
parameters to 20 mm x 20 mm. Finally expand Standard slice geometry interface 
and set it to 0.8 mm. 
13. Tune and match your sample again by choosing wobble from Acquire drop down 
menu on spectrometer control tool. 
14. Select EPI-diffusion-tensor scan and go to geometry editor  on Scan control 
window. Load corresponding RARE_Tripilot scan and set number of slices to 19. 
Make sure that slices cover entire brain on sagittal image and click accept. Now 








Post-Processing of DTI Data (ParaVision A07_Tools, O8_ImDispProcTool, 
O9_MPR_DTI_VISU) 
15. Dataset obtained from EPI-diffusion-tensor scan must be post processed. Open 
Image Display window if not already there by going to System 
ControlToolsImage Display & Processing. 
16. Select scan from window in ParaVision scan control and then from Image Display 
& Processing, choose the Processing drop down menu. From here click DTI 
Tensor Reconstruction All Slices. 
17. The reconstructed set of slices should appear as new dataset in scan control menu; 
if it does not then click scan, and scroll to the scan ID which has one greater third 
coordinate value. For example, if reconstructing scan 1.5.1, the new dataset would 
be 1.5.2. 
18. The reconstructed dataset contains tensor trace images, Fractional Anisotropy 
images, A0 images, eigenvalue and eigenvector images. 
19. To determine fractional anisotropy values select fractional anisotropy image 
corresponding to structure of interest on Image Display & Processing window.  
Next, choose the region of interest ROI tool from the top panel in the window and 





                               
 
20. Click command button New to highlight a tract or bundle within the coronal 
image. To allow for flexibility, choose the ROI type Track and outline the region 
you would like to analyze. The ROI tool window will expand allowing user to 
select for desired intensity regions within the traced portion using the sliders 
‘Min. Intensity’ and ‘Max. Intensity. 
                          
                                                                                                                             
          
21. On ROI tool click the radio button ‘Display’ which will calculate and display the 





value of the source displayed in the statistics and histogram window. 
                                           
 
 
22. To calculate mean diffusivity or the Apparent Diffusion Coefficient  (ADC), 
utilize the Image Sequence Analysis tool from the drop down ‘Processing’ Menu 
on the Image Display & Processing window. This should render a main ISA 
(Image Sequence Analysis) window. Make sure that you are analyzing diffusion 
tensor trace image. 
23. Click New ISA ROI and now position and size the ROI tool over the region you 







24. Mean diffusivity value will be listed under ‘value’ column corresponding to 






25. To visualize color maps such as below (CIVM), select processed data set (e.g 
1.5.2) and  go to Processing drop down menu on Image Display & Processing 
WindowDTI Visualization. 
 







27. In Data Selection panel that is shown below, select A0 in image toolbar under 
Map and Trace Weighted Image in image toolbar under mask. 
 







29. Here is where the region within the image to be analyzed is delineated. To do this, 
click onto the right plane image (1) and adjust the threshold sliders (2) to cover all 
of brain; this is called setting the seed point. When satisfied, click Lock Seed 
Plane (3).  
30. Next, click forward arrow to display the composite images. The DTI 
Visualization will display a color coded map in accordance with the three 
eigenvectors (1[LeftRight] = Green, 2 [TopDown] = Blue, 3[InOut] = 
Red). Different colors thus illustrate different diffusion directions. 
 
31. Buttons next to Eigenvectors can be selected or unselected in order to allow for 






Appendix C. Stereotactic Neonatal Surgeries 
 This is a preliminary procedure for stereotactic surgeries on neonatal 
(postnatal day 1) mice and for the removal of their brains. Surgeries take place in surgery 
room L342 in the Wellesley College Animal Facilities. Preliminary experiments inject 
cresyl violet to indicate the success of bilateral injections in practice rounds; final 
experiments use adeno-associated virus containing HDAC1 cDNA and saline.  
1. Make sure to have sufficient levels of isoflurane and cresyl violet prior to set up.  
2. Place stereotax on operation table and center neonatal mouse upon platform on 
base of stereotax.  
3. Draw approximately 2 uL of cresyl violet into Hamilton syringe. Then place the 
syringe in the automatic injector accessory as shown below. Experimenters can 






4. Set up isoflurane chamber and valve regulator so that there is one tubing loop 
from isoflurane chamber to induction chamber via valve regulator to filter, and 










5. Tube in secondary loop has a notch that must be placed over the neonate’s nose in 
order to maintain a steady stream of anesthesia during procedure. The tubing 
should be placed on anterior portion of mouse bed prior to neonate placement 
                   
6. Make sure valve for tubing to induction chamber is turned perpendicular to 
regulator then turn on oxygen tank, set lower valve of regulator to 0.5 to 1 
Liters/minute of O2 and isoflurane dial between 4% and 5%. Place neonatal 
mouse pup in chamber and wait approximately ten minutes for mouse to fall 





          
 
7. Once the mouse is asleep, close valve for induction chamber by making knob 
parallel; turn valve corresponding to the stereotax perpendicular to regulator to 
allow for gas flow. Adjust isoflurane flow to 3%. 
8. Transfer mouse pup quickly into the mouse bed and make sure its nose fits the 
notch to sustain anesthesia.  






9. Secure the pup flat onto the mouse bed by fitting the metal loop around the neck 
and pulling down. 
10. Once the pup is secured, situate the needle above its head by rotating the upright 
holder and locking into place with metal knob. 
 
11. The stereotax allows for syringe adjustment in three planes; dorsal/ventral, 
posterior/anterior and medial/lateral. Adjustments are measured with a vernier 
scale, so that the syringe can be precisely moved to a set of coordinates relative to 
bregma, where the sagittal and coronal sutures intersect on the skull (Image 







        
12.  The syringe is first aligned on top of bregma and the needle is then brought to the 
following coordinates with the vernier scale. A/P: +0.75 mm, M/L: ±0.25 mm, 
D/V -0.75 mm. 
                                                  
 Example of coordinate reading on vernier scale of 5.17 cm or 51.7mm. 
13. Align syringe with anterior/posterior, medial/lateral coordinates first, and then 





14. Once syringe is inside, inject cresyl violet by lightly tapping on plunger. In this 
case, the volume injected is not significant; however in future experiments, 
automatic injector will be used and injection will occur over a 2 minute period. 
 Following injection, wait two minutes before slowly lifting the syringe out of 
skull by increasing dorsal/ventral coordinate value. Same procedure is done on 
both sides of bregma. 
Brain removal conducted as preliminary test for proper coordinates.  
 
15. Once the injections are completed, pups are decapitated using surgery scissors 
(a,b). Reference photos borrowed from Beaudoin et al. 2012.  
          
 
16.  A longitudinal incision bisecting the skull is then produced and tweezers are used 
to peel the skull to the sides of the head (b,c,d). The incision should start at back 






17. A spatula should then be passed along the outer perimeter of the brain to carve out 
and separate it from the base of the skull. 
18. Once brain is free, transfer it to non-stick surface and use a blade to cut through 
the interhemispheric fissure (image below of Adult mouse brain borrowed from 
Airey and Williams 2001). 
                                            
                          
19. Confirm injection of dye by examining cingulate cortex using mouse atlas for 
guidance; Allen Reference Atlas for mouse, brain of PND 56 mouse shown. 
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